AtriCure, Inc. @AtriCure.•
11.18.2026
AtriCure, Inc. @AtriCure.•
11.17.2026
New-onset Afib is the most common complication after cardiac surgery. The BoxX-NoAF Clinical Trial is exploring if post-op Afib can be reduced.
This innovative trial will set out to evaluate if cardiac ablation and LAA exclusion during cardiac surgery is effective in the reduction of new-onset Afib in cardiac surgery patients with risk factors, but no history of Afib.
Stroke Awareness
Duration: 00:40
Addressing Afib Early
Duration: 1:11
BoxX-NoAF Trial
Duration: 00:24
Afib Goes Undertreated and Underdiagnosed in CABG Patients
Duration: 00:8
social media channels to keep updated on the latest at AtriCure.